Research work · 2017

Evolving Gene Therapy in Primary Immunodeficiency.

Molecular therapy : the journal of the American Society of Gene Therapy

Abstract

Prior to the first successful bone marrow transplant in 1968, patients born with severe combined immunodeficiency (SCID) invariably died. Today, with a widening availability of newborn screening, major improvements in the application of allogeneic procedures, and the emergence of successful hematopoietic stem and progenitor cell (HSC/P) gene therapy, the majority of these children can be identified and cured. Here, we trace key steps in the development of clinical gene therapy for SCID and other primary immunodeficiencies (PIDs), and review the prospects for adoption of new targets and technologies.

Download PDF

DOI: 10.1016/j.ymthe.2017.03.018